XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stock-Based Compensation Expense The following table presents stock-based compensation expense in the Company’s consolidated statements of comprehensive income:

 

 

 

For the Years Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

Cost of product revenue

 

$

2,021

 

 

$

1,929

 

 

$

1,368

 

Research and development

 

 

2,856

 

 

 

1,534

 

 

 

1,373

 

Selling, general and administrative

 

 

22,623

 

 

 

13,544

 

 

 

10,106

 

Total stock-based compensation

 

$

27,500

 

 

$

17,007

 

 

$

12,847

 

Estimated Weighted Average Assumptions

The fair value of stock option awards granted during the years ended December 31, 2021, 2020 and 2019 were calculated using the following estimated assumptions:

 

 

 

For the Years Ended December 31,

 

 

2021

 

2020

 

2019

Expected term (in years)

 

5.5-6.5

 

5.5-6.5

 

5.5-6.5

Expected volatility (range)

 

44.57-45.27%

 

45.14-50.87%

 

45.14-50.87%

Risk-free interest rate

 

0.77-1.07%

 

0.34-1.15%

 

1.55-2.56%

Expected dividend yield

 

0%

 

0%

 

0%

Summary of Option Activity

Information regarding option activity for the year ended December 31, 2021 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted
average
exercise
price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in Thousands)

 

Options outstanding at December 31, 2020

 

 

696,711

 

 

$

43.88

 

 

 

6.90

 

 

$

102,958

 

Granted

 

 

38,824

 

 

$

202.88

 

 

 

 

 

 

 

Exercised

 

 

(98,428

)

 

$

39.36

 

 

 

 

 

 

 

Forfeited/expired/cancelled

 

 

(12,000

)

 

$

60.95

 

 

 

 

 

 

 

Options outstanding at December 31, 2021

 

 

625,107

 

 

$

54.15

 

 

 

6.29

 

 

$

131,707

 

Options exercisable at December 31, 2021

 

 

326,416

 

 

$

37.41

 

 

 

5.61

 

 

$

74,238

 

Vested and expected to vest at December 31, 2021(1)

 

 

606,465

 

 

 

 

 

 

6.28

 

 

$

127,889

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Represents the number of vested options as of December 31, 2021 plus the number of unvested options expected to vest as of December 31, 2021 based on the unvested outstanding options at December 31, 2021 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.
Summary of Restricted Stock Unit Activity Information regarding stock unit activity, which includes

activity for restricted stock units and performance stock units, for the year ended December 31, 2021 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in Thousands)

 

Unvested at December 31, 2020

 

 

665,540

 

 

 

3.32

 

 

$

127,904

 

Awarded

 

 

187,588

 

 

 

 

 

 

 

Vested

 

 

(212,329

)

 

 

 

 

 

 

Forfeited/expired/cancelled

 

 

(34,114

)

 

 

 

 

 

 

Unvested at December 31, 2021

 

 

606,685

 

 

 

3.07

 

 

$

160,674

 

Vested and expected to vest at December 31, 2021(1)

 

 

613,606

 

 

 

2.48

 

 

$

162,507

 

 

(1)
Represents the number of vested stock units as of December 31, 2021 plus the number of unvested stock units expected to vest as of December 31, 2021 based on the unvested outstanding stock units at December 31, 2021 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.